It is consistent with the observation described previously by Aust et al. [36] who noticed, in their study, that coexpression of PELP1 and ESR2 proteins was associated with better prognosis for patients with epithelial ovarian cancer. The gene discussed is ESR2; the disease is ovarian carcinoma.